default image
Integrated platform for high-throughput synthesis and particle size screening of micro and nano scale self-assemblies
Efficiently and accurately regulate nano-drug carriers and quickly screen the best synthesis plan.
Type
Equipment
Tags
Other
Information & systems
Integrated platform
High throughput synthesis
Micro and nano scale self-assembly
Solution maturity
Development / Pilot validation
Cooperation methods
Other
Applicable industry
Health and social work
Applications
Drug development
Key innovations
The innovation of this green technology product lies in: integrating multiple technologies to achieve efficient automated screening, solving stability and efficiency issues in drug carrier research and development, quickly determining the best parameters and applying them to large-scale production, significantly improving research and development efficiency and product quality.
Potential economic benefits
This green technology product can improve the efficiency of drug carrier research and development and reduce production costs. Screening the best parameters through automation and machine learning, shortening the research and development cycle, and achieving rapid large-scale production, with significant economic benefits and market potential.
Potential climate benefits
The equipment improves research and development efficiency and reduces material waste and energy consumption by optimizing particle size control of drug carriers. Automation and high-throughput features reduce labor costs and time costs, indirectly promote energy conservation and emission reduction, and achieve green research and development.
Solution supplier
View more
Shanghai Institute of Silicate, Chinese Academy of Sciences
Shanghai Institute of Silicate, Chinese Academy of Sciences
The Shanghai Institute of Silicate, Chinese Academy of Sciences, focuses on the research of advanced inorganic materials and supports high-tech industries and major national needs.
Shanghai,China
Solution details

1. application field

This equipment platform can be used for particle size control research on drug carriers including liposomes, polymer micelles, drug-loaded microspheres and metal-organic framework particles. It solves the problems of poor batch stability of particulate products, cumbersome and inefficient labor to control parameters in the research and development process of micro and nano scale self-assemblies.

2. technical characteristics

The platform effectively combines advanced technologies such as microfluidic self-assembly synthesis, high-throughput experimental screening and automated control. It can automatically adjust multiple technical parameters such as microfluidic synthesis driving method, flow rate, reaction raw material concentration, solvent type and ratio. Self-assembled particle solution samples obtained from different parameter combinations are continuously and automatically subjected to steps such as collection, purification, dilution and online particle size detection. Finally, the best technical parameter combination is quickly screened out based on machine learning. and is directly applied to macro synthesis.

3. performance Index

Single batch of 48 samples, continuous synthesis, collection, inspection, data storage and analysis of 50 batches (completed in about 12 hours) of nanopharmaceutical samples; compatible with multiple microfluidic synthetic chip structures; the syringe pump flow rate is 1 ml/The range of min-100ml/min is adjustable; the best synthesis scheme is selected within 24 hours.

4. current state

Complete prototype development.

Last updated
08:28:42, Nov 05, 2025
Information contributed by

See original page on

Report